(Q28294769)

5

0 references

author name string

Heidelinde Jakel

1

0 references

Maxime Nowak

2

0 references

Audrey Helleboid-Chapman

3

0 references

Jamila Fruchart-Najib

Evidence that triglycerides are an independent coronary heart disease risk factor

4

0 references

language of work or name

English

0 references

publication date

2006

0 references

published in

Annals of Medicine

0 references

volume

38

0 references

issue

1

0 references

page(s)

2-10

0 references

cites work

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Common mutations of the lipoprotein lipase gene and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Structure and interfacial properties of human apolipoprotein A-V

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

T-1131-->C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The apoAI-CIII-AIV gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Genetic variants in Apolipoprotein AV alter triglyceride concentrations in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

SNP3 polymorphism in apo A-V gene is associated with small dense LDL particles in Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Determination of the functionality of common APOA5 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Identification of the human ApoAV gene as a novel RORalpha target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor RORalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Plasma triglyceride metabolism in thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Thyroid hormone regulates the hypotriglyceridemic gene APOA5

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Serum concentrations of remnant-like particles in hypothyroid patients before and after thyroxine replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Acute-phase proteins and other systemic responses to inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Infection and inflammation-induced proatherogenic changes of lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488

Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890500407488